Ruxolitinib Cream Is Tolerable and Effective in Cutaneous GVHD
A cream formulation of ruxolitinib was deemed safe and effective compared with placebo in patients with cutaneous graft-versus-host disease.
Source: onclive.com
Stay updated with breaking news from Clinical Condition. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
A cream formulation of ruxolitinib was deemed safe and effective compared with placebo in patients with cutaneous graft-versus-host disease.
Assessing clinical care and perinatal outcomes for women with preeclampsia/ eclampsia admitted to health facilities in Ethiopia